Related Experiment Video
Updated: May 10, 2026
08:41
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Cholecystectomy and NAFLD: does gallbladder removal have metabolic consequences?
The American Journal of Gastroenterology
|June 6, 2013
Summary
Cholecystectomy, gallbladder removal surgery, is linked to nonalcoholic fatty liver disease (NAFLD). Gallstones themselves are not associated with NAFLD, suggesting the surgery may be a contributing factor.
Area of Science:
- Hepatology and Gastroenterology
- Metabolic Syndrome Research
- Surgical Outcomes Analysis
Background:
- Nonalcoholic fatty liver disease (NAFLD) and gallbladder (GB) disease share metabolic syndrome risk factors.
- Cholecystectomy is a common surgical procedure for GB disease.
- Existing research highlights the complexity of NAFLD pathogenesis.
Discussion:
- A study using NHANES data found NAFLD is associated with cholecystectomy (OR=2.4), but not gallstones (OR=1.1).
- This suggests cholecystectomy, not gallstones, may be a risk factor for NAFLD.
- The gallbladder's role in metabolic regulation is increasingly recognized.
Key Insights:
- Cholecystectomy is significantly associated with NAFLD development.
- Gallstones alone do not show a statistically significant association with NAFLD.
- The surgical removal of the gallbladder may impact liver health.
Outlook:
- Further research is needed to elucidate the mechanisms linking cholecystectomy to NAFLD.
- Investigating the role of bile acid alterations post-cholecystectomy is crucial.
- Public health implications of cholecystectomy as a potential NAFLD risk factor warrant attention.
Related Concept Videos
01:20Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment: